[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336388-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336388-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","disulfiram-a-novel-repurposed-drug-for-cancer-therapy","Disulfiram - A novel repurposed drug for cancer therapy","","Cancer remains a major global health challenge. Drug repurposing offers a practical path to new therapies by identifying anticancer uses for already approved drugs, potentially lowering research cost, shortening development time, and improving safety. Disulfiram (DSF), originally FDA-approved for chronic alcoholism, shows promise as an anticancer agent against diverse malignancies. Evidence supports strong antitumor effects of DSF, especially when combined with copper (DSF/Cu), across cancers such as glioblastoma, breast, liver, pancreatic, and melanoma.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/disulfiram-a-novel-repurposed-drug-for-cancer-therapy/336388/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/disulfiram-a-novel-repurposed-drug-for-cancer-therapy/336388.png","ImageObject",300,407,{"name":42,"@type":43},"Violet","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is drug repurposing considered a promising strategy for cancer therapy?","Question",{"text":63,"@type":64},"Drug repurposing identifies new therapeutic uses for approved drugs, which can reduce research costs, shorten development time, and improve efficiency and safety compared with developing entirely new drugs.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What cancers are associated with reported anticancer effects of DSF/Cu?",{"text":68,"@type":64},"Studies report antitumor effects of DSF/Cu across multiple cancers, including glioblastoma, breast cancer, liver cancer, pancreatic cancer, and melanoma.",{"name":70,"@type":61,"acceptedAnswer":71},"Which molecular mechanisms are highlighted for DSF/Cu in inhibiting tumors?",{"text":72,"@type":64},"The review emphasizes induction of intracellular reactive oxygen species (ROS), multiple cell death signaling pathways, inhibition of proteasome activity, suppression of NF-kB signaling, and targeting of cancer stem cells, along with effects on drug resistance and metastasis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336388,1790342774,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","Disulfiram: A novel repurposed drug for cancer therapy  \nMin Zeng1, Baibei Wu2, Wenjie Wei3, Zihan Jiang1, Peiqiang Li1, Yuanting Quan1, Xiaobo Hu1,2  \n1Department of Biochemistry and Molecular Biology, School of Basic Medicine , Hengyang Medical School , University of South China , Hengyang , Hunan 421001 , China;  \n2The Key Laboratory of Ecological Environment and Critical Human Diseases Prevention of Hunan Province Department of Education , Hengyang Medical School , University of South China, Hengyang , Hunan 421001 , China;  \n3Institute of Biochemistry of Hengyang Medical School , University of South China , Hengyang , Hunan 421001 , China.  \nAbstract  \nCancer is a major global health issue. Effective therapeutic strategies can prolong patients’ survival and reduce the costs of treatment. Drug repurposing, which identifies new therapeutic uses for approved drugs, is a promising approach with the advantages of reducing research costs, shortening development time, and increasing efficiency and safety. Disulfiram (DSF), a Food and Drug Administration (FDA)-approved drug used to treat chronic alcoholism, has a great potential as an anticancer drug by targeting diverse human malignancies. Several studies show the antitumor effects of DSF, particularly the combination of DSF and copper (DSF/Cu), on a wide range of cancers such as glioblastoma (GBM), breast cancer, liver cancer, pancreatic cancer, and melanoma. In this review, we summarize the antitumor mechanisms of DSF/Cu, including induction of intracellular reactive oxygen species (ROS) and various cell death signaling pathways, and inhibition of proteasome activity, as well as inhibition of nuclear factor-kappa B (NF-kB) signaling. Furthermore, we highlight the ability of DSF/Cu to target cancer stem cells (CSCs), which provides a new approach to prevent tumor recurrence and metastasis. Strikingly, DSF/Cu inhibits several molecular targets associated with drug resistance, and therefore it is becoming a novel option to increase the sensitivity of chemo-resistant and radio-resistant patients. Studies of DSF/Cu may shed light on its improved application to clinical tumor treatment.  \nKeywords: Disulfiram; Aldehyde dehydrogenase; Reactive oxygen species; Proteasome activity; Cancer stem cells; Drug resistance  \nIntroduction  \nCancer is becoming one of the most common causes of death, and its prevalence is expected to increase worldwide. [1] Developing effective new pharmacotherapies improves survival and reduces mortality of patients with cancer. Currently, in addition to radical surgery, radiotherapy, and immunotherapy, chemotherapy that employs broad-spectrum cytotoxic drugs remains one of the most effective cancer treatments, despite having significant side effects. [2] Thus, discovering new anticancer drugs is of great importance for fulfilling a highly unmet medical need. However, developing new anticancer drugs is challenging because of high cost and being time consuming. To overcome these challenges, drug repurposing is a practical alternative strategy for using approved drugs with known toxicological and pharmacokinetic characteristics for new indications, which saves research costs and reduces the time to find new ways to treat various diseases. [3,4]  \n\n| Access this article online |  |\n| --- | --- |\n| Quick Response Code:\u003Cbr>| Website:\u003Cbr>[www.cmj.org](www.cmj.org) |\n|  | DOI:\u003Cbr>10. 1097/CM9 .0000000000002909 |\n\nDisulfiram (DSF), the Food and Drug Administration (FDA) -approved drug to treat chronic alcoholism, has been used since 1951 and is well tolerated with minimal side effects. [5] DSF irreversibly inhibits the activity of aldehyde dehydrogenase (ALDH), leading to excessive accumulation of acetaldehyde in the body, thereby establishing the alcohol aversion reflex. [6] Recently, growing evidence shows the potential of repurposing DSF to treat various pathologies such as inflammation, Lyme disease, metabolic disorders, and cancer. [7–10] Numerous mechanistic stud","cbCaijh9kR7tvVab","https://ap.wps.com/l/cbCaijh9kR7tvVab","pdf",2370306,"English","# Abstract\n# Introduction\n# Anticancer Mechanisms of DSF/Cu","[{\"question\":\"Why is drug repurposing considered a promising strategy for cancer therapy?\",\"answer\":\"Drug repurposing identifies new therapeutic uses for approved drugs, which can reduce research costs, shorten development time, and improve efficiency and safety compared with developing entirely new drugs.\"},{\"question\":\"What cancers are associated with reported anticancer effects of DSF/Cu?\",\"answer\":\"Studies report antitumor effects of DSF/Cu across multiple cancers, including glioblastoma, breast cancer, liver cancer, pancreatic cancer, and melanoma.\"},{\"question\":\"Which molecular mechanisms are highlighted for DSF/Cu in inhibiting tumors?\",\"answer\":\"The review emphasizes induction of intracellular reactive oxygen species (ROS), multiple cell death signaling pathways, inhibition of proteasome activity, suppression of NF-kB signaling, and targeting of cancer stem cells, along with effects on drug resistance and metastasis.\"}]","Disulfiram - A novel repurposed drug for cancer therapy | PDF",1790014817,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7b7e42c13ec4b86c9b6c89f37c6e93d.webp",983,1324,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b61a170a8d8082c243b1e6c52d798f09.webp",982,1322,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/983f8a069fc1740fdc2ce042e1a9d328.webp",981,1321,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/57a7b364d915eb79ea85fb91769e0ee3.webp",980,1319]